Inspirata and Leica Biosystems Sign Agreement to add Aperio Digital Pathology Scanners to Inspirata’s end-to-end Workflow Solution Portfolio
Washington, DC, October 10, 2017/Globe Newswire – Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has finalized an agreement with Leica Biosystems to expand the portfolio of scanning devices it delivers to clients as part of its end-to-end digital pathology workflow solution.
The agreement encompasses Leica Biosystems entire suite of scanners. It spans scanners for a diverse set of applications ranging from large scanners for high-volume scanning centers to more specialized instruments like oil immersion, live microscopy and fluorescence scanners.
“For example,” says Inspirata Founder and Executive Vice President, Mark Lloyd, PhD, MSM, “the Aperio AT2 digital whole slide scanner, with a capacity of 400 slides, makes it an ideal choice for high-throughput scenarios such as those we encounter at institutions with high volumes of active cases and large slide archives.”
Inspirata’s end-to-end digital pathology workflow solution employs a unique, “Solution-as-a-Service” business model designed to help academic medical centers overcome the financial barrier to adoption by making the upfront capital investment in the digital pathology instrumentation, hardware, software and storage. Inspirata also does the workflow requirements analysis and complete project planning and program management. Integration services, operational staffing and management, and technical support are included along with scan lab staffing to do retrospective and prospective histopathology slide scanning, as well as cockpits for each of the hospital’s pathologists.
“We are pleased to add Leica Biosystems world-class instrumentation to the growing portfolio of scanners available as part of our workflow solution,” says Inspirata’s CEO Satish Sanan. “This new agreement enables us to offer the academic medical centers we work with best-of-breed options for just about any pathology use case we can envision.”
Vice President and General Manager, Leica Biosystems Pathology Imaging Business, Jerome Clavel, further comments, “We look forward to leveraging Inspirata’s expertise in cancer informatics and their understanding of large-scale workflow solution implementations.”
About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact firstname.lastname@example.org.